Reuters logo
BRIEF-Concert Pharma says FDA lifts clinical hold on its clinical trial with CTP-543
July 10, 2017 / 12:12 PM / 5 months ago

BRIEF-Concert Pharma says FDA lifts clinical hold on its clinical trial with CTP-543

July 10 (Reuters) - Concert Pharmaceuticals Inc

* Fda lifts clinical hold on concert pharmaceuticals clinical trial with ctp-543

* Concert pharmaceuticals inc - ‍concert to resume enrollment in modified phase 2a trial for alopecia areata​

* Concert pharmaceuticals inc - ‍company will amend protocol for phase 2a trial to evaluate two doses of ctp-543​

* Concert pharmaceuticals inc - ‍expects to complete phase 2a trial second half of 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below